The main finding of our study was the observed reduction in JAK2/STAT3 phosphorylation after MN treatment, indicating that inhibition of the JAK and STAT pathways may be involved in MN treatment of colitis, which is associated with pro-inflammatory cytokine gene expression. The gene discussed is SOAT1; the disease is colitis.